Matthew Biegler
Stock Analyst at Oppenheimer
Total Price Targets
17
Stocks Covered
8
Sectors
Healthcare
Most Recent
Mar 16, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Matthew Biegler
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $12.00 | $4.16 | +188.8% | 2 | Mar 16, 2026 |
| ORIC | ORIC Pharmaceuticals, Inc. | $15.00 | $9.88 | +51.8% | 3 | Feb 24, 2026 |
| NRIX | Nurix Therapeutics, Inc. | $28.00 | $16.83 | +66.4% | 4 | Oct 10, 2025 |
| TYRA | Tyra Biosciences, Inc. | $36.00 | $34.09 | +5.6% | 1 | Sep 10, 2025 |
| IDYA | IDEAYA Biosciences, Inc. | $36.00 | $28.27 | +27.4% | 2 | Sep 8, 2025 |
| ARVN | Arvinas, Inc. | $40.00 | $10.55 | +279.0% | 2 | Oct 31, 2024 |
| ACRV | Acrivon Therapeutics, Inc. Common Stock | $18.00 | $2.05 | +778.0% | 2 | Aug 13, 2024 |
| FATE | Fate Therapeutics, Inc. | $135.00 | $1.55 | +8581.7% | 1 | Dec 13, 2021 |
Recent Activity
- Mar 16, 2026— Set$12.00price target onCTMX(CytomX Therapeutics, Inc.)
- Feb 24, 2026— Set$15.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Oct 10, 2025— Set$28.00price target onNRIX(Nurix Therapeutics, Inc.)
- Sep 10, 2025— Set$36.00price target onTYRA(Tyra Biosciences, Inc.)
- Sep 8, 2025— Set$36.00price target onIDYA(IDEAYA Biosciences, Inc.)
- Jul 31, 2025— Set$7.00price target onCTMX(CytomX Therapeutics, Inc.)
- Jul 10, 2025— Set$30.00price target onNRIX(Nurix Therapeutics, Inc.)
- May 6, 2025— Set$12.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Oct 31, 2024— Set$40.00price target onARVN(Arvinas, Inc.)
- Oct 15, 2024— Set$35.00price target onNRIX(Nurix Therapeutics, Inc.)
- Aug 14, 2024— Set$27.00price target onNRIX(Nurix Therapeutics, Inc.)
- Aug 13, 2024— Set$18.00price target onACRV(Acrivon Therapeutics, Inc. Common Stock)
- Aug 7, 2024— Set$53.00price target onIDYA(IDEAYA Biosciences, Inc.)
- May 16, 2024— Set$70.00price target onARVN(Arvinas, Inc.)
- May 14, 2024— Set$21.00price target onACRV(Acrivon Therapeutics, Inc. Common Stock)
- Mar 12, 2024— Set$17.00price target onORIC(ORIC Pharmaceuticals, Inc.)
- Dec 13, 2021— Set$135.00price target onFATE(Fate Therapeutics, Inc.)
Frequently Asked Questions
Who is Matthew Biegler?
Matthew Biegler is a stock analyst at Oppenheimer covering 8 stocks primarily in Healthcare. They have issued 17 price targets since Dec 13, 2021.
What stocks does Matthew Biegler cover?
Matthew Biegler currently covers 8 stocks, including NRIX, ORIC, CTMX, IDYA, ARVN.
What is Matthew Biegler's latest price target?
Matthew Biegler's most recent price target was $12.00 on CTMX (CytomX Therapeutics, Inc.), set on Mar 16, 2026.
What is Matthew Biegler's highest price target?
Matthew Biegler's highest issued price target is $135.00 on FATE, set on Dec 13, 2021.
More Analysts at Oppenheimer
Coverage based on publicly published price targets. Not investment advice.